Table 3.
Results of univariate analysis of overall survival in patients with mCRC
Variables | Hazard ratio | 95%CI | P-value |
---|---|---|---|
Age (years) (≥ 65 versus < 65) | 0.918 | 0.56–1.261 | 0.400 |
Gender | 1.432 | 1.037–1.977 | 0.029 |
MPV (≥ 9.75 fL versus < 9.75 fL) | 1.398 | 1.005–1.946 | 0.047 |
WBC | 1.082 | 1.018–1.150 | 0.011 |
ANC | 1.084 | 1.016–1.157 | 0.015 |
Lymphocyte | 0.861 | 0.64–1.157 | 0.320 |
Hemoglobin (≤120 × 109/L vs.>120 × 109/L) | 0.630 | 0.453–0.87 | 0.006 |
PLT | 1.002 | 1–1.003 | 0.018 |
PCT | 4.234 | 1.17–15.322 | 0.028 |
PDW | 0.961 | 0.901–1.026 | 0.234 |
PLR | 1.003 | 1–1.004 | 0.002 |
NLR | 1.066 | 1.007–1.128 | 0.028 |
Efficacy | 1.529 | 1.285–1.820 | 0.000 |